CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 180 enrolled
Drug / intervention
Restylane® +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00935272
NCT00935272N/ACompleted

A Randomized, Evaluator-Blinded, No-Treatment-Controlled Study of the Effectiveness and Safety of Restylane® in the Augmentation of Soft Tissue Fullness of the Lips

Medicis Global Service Corporation·interventional·Posted Jul 9, 2009·Updated Jan 30, 2012

In Brief

A clinical study evaluating Restylane® and Non-Treatment for Lip Augmentation. Completed, enrolled 180 participants across 12 sites.

Detailed Summary

To determine the safety and effectiveness of Restylane® when used for lip augmentation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 9, 2009
Enrollment StartJul 1, 2009
Primary CompletionJun 1, 2010
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.0 years ago

Interventions

Restylane®device

Restylane® injections in the lips

Non-Treatmentdevice

Non- Treatment